NFKBIL1 confers resistance to experimental autoimmune arthritis through the regulation of dendritic cell functions

Scandinavian Journal of Immunology

Volumn 73, Issue 5, 2011, Pages 478-485

  Chiba, T ^a   Matsuzaka, Y ^a   Warita, T ^a   Sugoh, T ^a   Miyashita, K ^a   Tajima, A ^a   Nakamura, M ^a   Inoko, H ^a   Sato, T ^a   Kimura, M ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; NUCLEAR FACTOR; NUCLEAR FACTOR KAPPA B INHIBITOR LIKE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTHRITIS; ARTICLE; AUTOIMMUNE ARTHRITIS; B LYMPHOCYTE; BONE MARROW; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNE RESPONSE; INNATE IMMUNITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CYTOKINES; DENDRITIC CELLS; DNA-BINDING PROTEINS; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED DBA; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 79953048861     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02524.x     Document Type: Article

References (27)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
2. Leung BP, Conacher M, Hunter D, McInnes IB, Liew FY, Brewer JM. A novel dendritic cell-induced model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction of local inflammation. J Immunol 2002;169:7071-7.
3. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007;7:429-42.
4. Yap DY, Lai KN. Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol 2010;2010:365083.
5. Renner F, Schmitz ML. Autoregulatory feedback loops terminating the NF-kappaB response. Trends Biochem Sci 2009;34:128-35.
6. van der Helm-van Mil AH, Wesoly JZ, Huizinga TW. Understanding the genetic contribution to rheumatoid arthritis. Curr Opin Rheumatol 2005;17:299-304.
7. Okamoto K, Makino S, Yoshikawa Y et al. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 2003;72:303-12.
8. Lin CH, Cho CL, Tsai WC et al. Inhibitors of kB-like gene polymorphisms in rheumatoid arthritis. Immunol Lett 2006;105:193-7.
9. Handel-Fernandez ME, Vincek V. Sequence analysis and expression of a mouse homolog of human IkappaBL gene. Biochim Biophys Acta 1999;1444:306-10.
10. Greetham D, Ellis CD, Mewar D et al. Functional characterization of NF-kappaB inhibitor-like protein 1 (NFkappaBIL1), a candidate susceptibility gene for rheumatoid arthritis. Hum Mol Genet 2007;16:3027-36.
11. Seki N, Sudo Y, Yoshioka T et al. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 1988;140:1477-84.
12. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004;117:265-77.
13. Shibata H, Yasunami M, Obuchi N et al. Direct determination of single nucleotide polymorphism haplotype of NFKBIL1 promoter polymorphism by DNA conformation analysis and its application to association study of chronic inflammatory diseases. Hum Immunol 2006;67:363-73.
14. Yamashita T, Hamaguchi K, Kusuda Y, Kimura A, Sakata T, Yoshimatsu H. IKBL promoter polymorphism is strongly associated with resistance to type 1 diabetes in Japanese. Tissue Antigens 2004;63:223-30.
15. de la Concha EG, Fernandez-Arquero M, Lopez-Nava G et al. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology 2000;119:1491-5.
16. Castiblanco J, Anaya JM. The IkappaBL gene polymorphism influences risk of acquiring systemic lupus erythematosus and Sjogren's syndrome. Hum Immunol 2008;69:45-51.
17. Kominami S, Tanabe N, Ota M et al. HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis. J Hum Genet 2009;54:108-14.
18. Wang J, Fathman JW, Lugo-Villarino G et al. Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. J Clin Invest 2006;116:414-21.
19. Tada Y, Nagasawa K, Ho A et al. CD28-deficient mice are highly resistant to collagen-induced arthritis. J Immunol 1999;162:203-8.
20. Iwai H, Kozono Y, Hirose S et al. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J Immunol 2002;169:4332-9.
21. Kagari T, Doi H, Shimozato T. The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol 2002;169:1459-66.
22. Kaisho T, Akira S. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol 2001;22:78-83.
23. Semple JI, Brown SE, Sanderson CM, Campbell RD. A distinct bipartite motif is required for the localization of inhibitory kappaB-like (IkappaBL) protein to nuclear speckles. Biochem J 2002;361:489-96.
24. Hirotani T, Lee PY, Kuwata H et al. The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J Immunol 2005;174:3650-7.
25. Kuwata H, Watanabe Y, Miyoshi H et al. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 2003;102:4123-9.
26. Kuwata H, Matsumoto M, Atarashi K et al. IkappaBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation. Immunity 2006;24:41-51.
27. Touma M, Antonini V, Kumar M et al. Functional role for I kappa BNS in T cell cytokine regulation as revealed by targeted gene disruption. J Immunol 2007;179:1681-92.